Kalle Känd

CEO

Kalle Kand has served as Chief Executive Officer of MS Pharma since February 2020, bringing twenty-seven years of global and regional experience in the pharmaceutical and generics sector to the Amman-headquartered multinational, which develops, produces and distributes generic and speciality medicines across the META region with more than two thousand four hundred employees. Before MS Pharma he was Managing Partner at Kaper Pharma from December 2018 to January 2020 and served as Chief Executive and Chief Commercial Officer at Acino International AG from May 2014 to November 2018. Earlier in his career he was Vice President of Strategy for Emerging Markets at Takeda Pharmaceuticals, having joined the company, then known as Nycomed, in 2001 as Regional Director of Sales and Marketing.